Document is current
Any future updates will be listed below
-
Authors
Kang, Eun Young
Millstein, Joshua
Popovic, Gordana
Meagher, Nicola S.
Bolithon, Adelyn
Talhouk, Aline
Chiu, Derek S.
Anglesio, Michael S.
Leung, Betty
Tang, Katrina
Lambie, Neil
Pavanello, Marina
Da-anoy, Annalyn
Lambrechts, Diether
Loverix, Liselore
Olbrecht, Siel
Bisinotto, Christiani
Garcia-Donas, Jesus
Ruiz-Llorente, Sergio
Yagüe-Fernandez, Monica
Edwards, Robert P.
Elishaev, Esther
Olawaiye, Alexander
Taylor, Sarah
Ataseven, Beyhan
du Bois, Andreas
Harter, Philipp
Lester, Jenny
Høgdall, Claus K.
Armasu, Sebastian M.
Huang, Yajue
Vierkant, Robert A.
Wang, Chen
Winham, Stacey J.
Heublein, Sabine
Kommoss, Felix K. F.
Cramer, Daniel W.
Sasamoto, Naoko
van-Wagensveld, Lilian
Lycke, Maria
Mateoiu, Constantina
Joseph, Janine
Pike, Malcolm C.
Odunsi, Kunle
Tseng, Chiu-Chen
Pearce, Celeste L.
Bilic, Sanela
Conrads, Thomas P.
Hartmann, Arndt
Hein, Alexander
Jones, Michael E.
Leung, Yee
Beckmann, Matthias W.
Ruebner, Matthias
Schoemaker, Minouk J.
Terry, Kathryn L.
El-Bahrawy, Mona A.
Coulson, Penny
Etter, John L.
LaVigne-Mager, Katherine
Andress, Juergen
Grube, Marcel
Fischer, Anna
Neudeck, Nina
Robertson, Greg
Farrell, Rhonda
Barlow, Ellen
Quinn, Carmel
Hettiaratchi, Anusha
Casablanca, Yovanni
Erber, Ramona
Stewart, Colin J. R.
Tan, Adeline
Yu, Yu
Boros, Jessica
Brand, Alison H.
Harnett, Paul R.
Kennedy, Catherine J.
Nevins, Nikilyn
Morgan, Terry
Fasching, Peter A.
Vergote, Ignace
Swerdlow, Anthony J.
Candido dos Reis, Francisco J.
Maxwell, G. Larry
Neuhausen, Susan L.
Barquin-Garcia, Arantzazu
Modugno, Francesmary
Moysich, Kirsten B.
Crowe, Philip J.
Hirasawa, Akira
Heitz, Florian
Karlan, Beth Y.
Goode, Ellen L.
Sinn, Peter
Horlings, Hugo M.
Høgdall, Estrid
Sundfeldt, Karin
Kommoss, Stefan
Staebler, Annette
Wu, Anna H.
Cohen, Paul A.
DeFazio, Anna
Lee, Cheng-Han
Steed, Helen
Le, Nhu D.
Gayther, Simon A.
Lawrenson, Kate
Pharoah, Paul D. P.
Konecny, Gottfried
Cook, Linda S.
Ramus, Susan J.
Kelemen, Linda E.
Köbel, Martin https://orcid.org/0000-0002-6615-2037
-
Funding
Funding for this research was provided by:
Alberta Precision Laboratories (RS19-612, RS10-526)
National Cancer Institute (R01CA172404, K07-CA80668, R01CA095023, R01 CA126841)
Medical Research and Materiel Command (DAMD17-02-1-0669)
National Center for Research Resources (MO1- RR000056)
Westmead Hospital Department of Gynaecological Oncology
National Health and Medical Research Council (310670, 628903)
Cancer Institute NSW (12/RIG/1-17, 15/RIG/1-16)
Sydney West Translational Cancer Research Centre
Breast Cancer Now
Institute of Cancer Research
Swedish Cancer Foundation
U.S. Defense Health Program (HU0001-16-2-0006, HU0001-19-2-0031)
BC Cancer Foundation
VGH and UBC Hospital Foundation
Michael Smith Foundation for Health Research
Heuer Stiftung für medizinische Forschung
University of Pittsburgh Dean's Faculty Advancement Fund
American Cancer Society (SIOP-06-258-01-COUN)
ALF-agreement
Assar Gabrielsson Foundation
National Cancer Institute (P30CA014089, P50-CA135393, R01-CA248288)
NSW Ministry of Health
University of New South Wales (NSW Health PhD Scholarship Program)
Translational Cancer Research Network
Dutch Cancer Society (IKNL2014-6838)
- License Information
-
More Information
Article History
Received: 13 September 2021
Revised: 19 October 2021
Accepted: 1 November 2021
First Online: 15 November 2021
Declarations
:
: All study sites received ethics board approval. Please refer to Supplementary Table .
: Not applicable.
: Not applicable.
: The authors have no relevant conflicts of interest regarding this publication. A. Hartmann has received honoraria from BMS, MSD, Roche, AstraZeneca, Boehringer Ingelheim, Abbvie, Jansen-Cilag, and Ipsen. R. Erber has received honoraria from Roche, Eisai, Pfizer, and Novartis and travel grants from BioNTech. The institution of A. Hartmann and R. Erber conducts research for AstraZeneca, Roche, Janssen-Cilag, NanoString Technologies, Novartis, Cepheid, and BioNTech. P. Harter’s honoraria: Astra Zeneca, GSK, Roche, Sotio, Stryker, Zai Lab, MSD, Clovis Advisory Board: Astra Zeneca, Roche, GSK, Clovis, Immunogen, MSD/Merck Research Funding (Inst): Astra Zeneca, Roche, GSK, Genmab, DFG, European Union, DKH, Immunogen, Clovis. T.P. Conrads is member of the Thermo Fisher Scientific Inc. scientific advisory board. P. A. Cohen received honoraria from Seqirus and Astra Zeneca.
